Company / Assets per Share
C4 Therapeutics, Inc. Assets per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$5.08
FY2025
5-year range
$5.08 / $8.85
FY2022-FY2025
Trend
-12.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has declined for 3 consecutive years, from $8.85 in FY2022 to $5.08 in FY2025.
Based on SEC 10-K filings.
5.08 in FY2025 with a 3-year CAGR of -16.9%.
Declined from $7.69 to $5.08 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -16.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- C4 Therapeutics, Inc.'s assets per share has declined for 3 consecutive years.
- In FY2025, assets per share decreased 12.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.08 | -12.1% |
| FY2024 | $5.78 | -24.8% |
| FY2023 | $7.69 | -13.1% |
| FY2022 | $8.85 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026